The discovery of the double helix of DNA (Article 59) revealed the structure of the genetic code, but to understand its function, scientists needed a method to read the exact sequence of the building blocks—the amino acids in proteins and the nucleotides in DNA. The chemist who provided these critical sequencing tools, setting the stage for the Human Genome Project (Article 65) and all modern biotechnology, was the British biochemist Frederick Sanger (1918–2013). Sanger is the only person to have been awarded the Nobel Prize in Chemistry twice (1958 and 1980).
Sanger’s initial triumph was solving the structure of the most crucial protein in metabolism: insulin.
The Challenge: Insulin is a relatively small protein composed of two chains of amino acids (A and B) linked by disulfide bonds. Determining the sequence of these amino acids was a massive chemical puzzle that had never been solved before.
The Method (Sanger’s Method): Sanger devised a technique using a chemical reagent (DNP-fluorobenzene) to specifically label the amino acid at the beginning (N-terminus) of the protein chain. He then used enzymes and acid hydrolysis to break the chains into smaller, overlapping fragments. By analyzing the composition of these fragments, he could piece the fragments together like a jigsaw puzzle to determine the complete sequence.
The Result: In 1955, Sanger successfully mapped the complete amino acid sequence of insulin. This was the first time any protein’s exact chemical structure had been fully determined. This proved that proteins have a fixed, genetically determined structure, directly supporting the idea that the sequence of DNA dictates the sequence of proteins.
After solving proteins, Sanger turned his attention to the much larger challenge of DNA sequencing.
The Challenge: DNA molecules are far larger than proteins. Early methods to determine their nucleotide order were inefficient.
The Method (Chain-Termination or Dideoxy Method): Sanger developed what became the definitive method for sequencing DNA, known as the Chain-Termination Method (or Sanger Sequencing). The technique uses a normal DNA polymerase enzyme to synthesize a new strand of DNA. Crucially, the reaction includes small amounts of specially modified nucleotides called dideoxy nucleotides (ddNTPs). When a ddNTP is incorporated into the growing DNA strand, it stops the strand's further elongation.
Reading the Code: By running four separate reactions, each containing a different fluorescently labeled ddNTP (A, T, C, or G), researchers could generate a ladder of DNA fragments, each fragment one base longer than the last. Running these fragments through a high-resolution gel or capillary tube allowed scientists to read the sequence one base at a time.
Sanger Sequencing dominated DNA analysis for three decades, becoming the technology that made the Human Genome Project possible. Although it has since been superseded by faster, cheaper Next-Generation Sequencing (NGS) technologies, Sanger’s pioneering work laid the conceptual and practical groundwork for all modern genomics.
In Conclusion: Frederick Sanger provided the essential methodological tools for the molecular biology revolution. By pioneering the sequencing of insulin and then inventing the dideoxy method for sequencing DNA, he moved biology from observing molecular structure to reading and understanding the chemical language of life. His work is the foundation of all modern efforts in genomics, personalized medicine, and biotechnology.